Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emerging trends in the clinical use of bortezomib in multiple myeloma.
Richardson PG, Schlossman R, Mitsiades C, Hideshima T, Munshi N, Anderson K. Richardson PG, et al. Among authors: anderson k. Clin Lymphoma Myeloma. 2005 Sep;6(2):84-8. doi: 10.3816/CLM.2005.n.033. Clin Lymphoma Myeloma. 2005. PMID: 16231845 Review.
Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantation.
Freedman A, Neuberg D, Mauch P, Gribben J, Soiffer R, Anderson K, Robertson M, Fisher DC, Schlossman R, Kroon M, Rhuda C, Kuhlman C, Ritz J, Nadler L. Freedman A, et al. Among authors: anderson k. Blood. 1997 Dec 15;90(12):4996-5001. Blood. 1997. PMID: 9389719 Free article.
Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.
Vescio R, Schiller G, Stewart AK, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, DiPersio J, Anderson K, Berenson J. Vescio R, et al. Among authors: anderson k. Blood. 1999 Mar 15;93(6):1858-68. Blood. 1999. PMID: 10068658 Free article. Clinical Trial.
Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Avigan D, Wu Z, Gong J, Joyce R, Levine J, Elias A, Richardson P, Milano J, Kennedy L, Anderson K, Kufe D. Avigan D, et al. Among authors: anderson k. Clin Cancer Res. 1999 Oct;5(10):2735-41. Clin Cancer Res. 1999. PMID: 10537336
T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.
Alyea E, Weller E, Schlossman R, Canning C, Webb I, Doss D, Mauch P, Marcus K, Fisher D, Freeman A, Parikh B, Gribben J, Soiffer R, Ritz J, Anderson K. Alyea E, et al. Among authors: anderson k. Blood. 2001 Aug 15;98(4):934-9. doi: 10.1182/blood.v98.4.934. Blood. 2001. PMID: 11493435 Free article. Clinical Trial.
Thalidomide: emerging role in cancer medicine.
Richardson P, Hideshima T, Anderson K. Richardson P, et al. Among authors: anderson k. Annu Rev Med. 2002;53:629-57. doi: 10.1146/annurev.med.53.082901.104043. Annu Rev Med. 2002. PMID: 11818493 Review.
Thalidomide in multiple myeloma.
Richardson P, Hideshima T, Anderson K. Richardson P, et al. Among authors: anderson k. Biomed Pharmacother. 2002 May;56(3):115-28. doi: 10.1016/s0753-3322(02)00168-3. Biomed Pharmacother. 2002. PMID: 12046682 Review.
8,357 results